Spearheaded the technology platform’s biochemistry and automation R&D, enabling quarter-over-quarter doubling of experimental throughput.

Inventor on 6 patent applications (2 published).

Led cross-organization teams in execution of grants/contracts/collaborative research for commercial, government, and academic stakeholders totaling >$1.5M revenue.

Learned Python and the Pandas library in free time outside of work for bulk experimental data processing and analysis.

Designed, tested, and deployed robust SOPs for automation, platform operation, and commercial applications and trained other team members to take over segments of platform operation.

Spearheaded execution of crucial pilot contracts with commercial partners that have formed the basis for the company’s current business model.

Learned Python and the Pandas library in free time outside of work for bulk experimental data processing and analysis.

Assisted in designing and deploying internal data infrastructure for managing high-throughput experimental data.

Represented the company at biotech and synthetic biology conferences around the world, including co-hosting an overbooked, standing-room-only seminar at SynBioBeta 2018.

Pioneered 100-fold reduction in base platform reagent cost without sacrificing genetic circuit prototyping capabilities and other key performance parameters.

Demonstrated sufficient technology improvement (cost, genetic circuit fidelity, repeatability/robustness) to secure additional DARPA funding to spin out as Synvitrobio, Inc. (DBA Tierra Biosciences) after 6 months.

Executed and assisted in characterization/functional studies of phenanthriplatin, a novel platinum anticancer agent.

Set up crystallization trials for phenanthriplatin-DNA conjugates to study binding interactions.

Maintained human tumor cell lines and evaluated effect of drug combinations via MTT assay for synergism.

Investigated transcription-inhibitory effects of platinum-based drugs by transfection with Gaussia luciferase expression vector-platinum drug adducts

Purified drug-conjugated vector by gel extraction, phenol-chloroform extraction, isopycnic centrifugation

Studied apoptotic effects of phenanthriplatin via JC-1 fluorescence microscopy

Produced recombinant Hsp90a via pET expression system.

Purified protein via nickel affinity chromatography, FPLC, gel electrophoresis.